DISMEVAL Developing and validating disease management evaluation methods for European healthcare systems

Final report

Edited by Ellen Nolte, Saba Hinrichs

ResearchPublished Apr 4, 2012

The report documents the overall findings of the work carried out within the DISMEVAL project which was funded under the European Commission's 7th Framework Programme. It sought to review current approaches to chronic care and their evaluations, as implemented by EU Member States at national and regional levels and to explore the policy context for chronic disease management in European countries. Reporting on the range of approaches to chronic care adopted in 13 European countries it emphasises the need for the development of a coherent response to chronic disease that takes account of the various tiers in the system and along the care continuum, with involvement of professionals forming a crucial component for achieving sustainable change. The DISMEVAL project further sought to test and validate different evaluation methods using existing data from disease management interventions in six countries. In doing so, it advances the research base in evaluation design and methodology, so informing the design of future evaluations and enhancing their value for decisionmaking. Work carried out identified and tested a wide range of methods that can be employed in situations where experimental approaches are not possible, emphasising that rigorous evaluation is still possible where baseline or predefined control groups are not available and how advanced designs can help better understand how different (combinations of) care components and processes might be effective for managing chronic disease in patients with different characteristics. It argues how future evaluation work drawing on such approaches should provide insight into what works for whom in the area of disease management, a question that randomised trials have thus far been unable to answer.

Topics

Document Details

  • Publisher: RAND Corporation
  • Availability: Web-Only
  • Year: 2012
  • Pages: 222
  • Document Number: TR-1226-EC

Citation

RAND Style Manual
Nolte, Ellen and Saba Hinrichs, eds., DISMEVAL Developing and validating disease management evaluation methods for European healthcare systems: Final report, RAND Corporation, TR-1226-EC, 2012. As of September 14, 2024: https://www.rand.org/pubs/technical_reports/TR1226.html
Chicago Manual of Style
Nolte, Ellen and Saba Hinrichs, eds., DISMEVAL Developing and validating disease management evaluation methods for European healthcare systems: Final report. Santa Monica, CA: RAND Corporation, 2012. https://www.rand.org/pubs/technical_reports/TR1226.html.
BibTeX RIS

Research conducted by

The reseach described in this document was prepared for the European Commission on behalf of the DISMEVAL Consortium and conducted by RAND Europe.

This publication is part of the RAND technical report series. RAND technical reports, products of RAND from 2003 to 2011, presented research findings on a topic limited in scope or intended for a narrow audience; discussions of the methodology employed in research; literature reviews, survey instruments, modeling exercises, guidelines for practitioners and research professionals, and supporting documentation; and preliminary findings. All RAND technical reports were subject to rigorous peer review to ensure high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.